{
    "clinical_study": {
        "@rank": "58736", 
        "arm_group": {
            "arm_group_label": "amniotic membrane in big wounds", 
            "arm_group_type": "Experimental", 
            "description": "The wound will be washed with saline and debrided if necessary. Control microbiological cultures will be taken and applied amniotic membrane fragments sufficient to cover the wound, putting in contact the basement membrane of the AM with granulation tissue"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine the safety of use of a new therapeutic strategy\n      for the treatment of patients with large wounds"
        }, 
        "brief_title": "Clinic Trial in Phase 1 Using Amniotic Membrane for the Skin Replacement in Big Wounds", 
        "completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Wound", 
        "detailed_description": {
            "textblock": "Amniotic membrane (AM) is a useful tissue as a biological dressing with numerous advantages\n      it has a very similar structure to the skin and his biological and immunological properties."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Acute wounds in granulation phase with a minimum surface of 100cm2\n\n          -  \u2265 18 years\n\n          -  signing informed consent form\n\n          -  guarantee adherence to protocol\n\n        Exclusion Criteria:\n\n          -  chronic arterial insufficiency\n\n          -  pregnant patients, lactating women or fertile adults that they don`t use an effective\n             contraceptive method\n\n          -  involved in other assay\n\n          -  previous disease; kidney, heart, hepatic, systemic or immune\n\n          -  inability to understand informed consent form"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "10", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 19, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01948934", 
            "org_study_id": "MA/GH", 
            "secondary_id": "2011-004395-11"
        }, 
        "intervention": {
            "arm_group_label": "amniotic membrane in big wounds", 
            "description": "The wound will be washed with saline and debrided if necessary. Control microbiological cultures will be taken and applied amniotic membrane fragments sufficient to cover the wound, putting in contact the basement membrane of the AM with granulation tissue", 
            "intervention_name": "Amniotic membrane in big wounds", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Skin", 
            "Injury", 
            "Membrane amniotic", 
            "Wound"
        ], 
        "lastchanged_date": "March 17, 2014", 
        "location": {
            "contact": {
                "last_name": "Gregorio Castellanos Escrig, MD"
            }, 
            "facility": {
                "address": {
                    "city": "Murcia", 
                    "country": "Spain", 
                    "state": "El Palmar", 
                    "zip": "30120"
                }, 
                "name": "Gregorio Castellanos Escrig MD"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Spain"
        }, 
        "number_of_arms": "1", 
        "official_title": "Clinic Trial in Phase 1 Using Amniotic Membrane for the Skin Replacement in Big Wounds", 
        "overall_contact": {
            "last_name": "Gregorio Castellanos Escrig, MD", 
            "phone": "968369500"
        }, 
        "overall_official": {
            "affiliation": "Hospital Clinico Universitario Virgen de la Arrixca", 
            "last_name": "Gregorio Castellanos Escrig, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Spain: Spanish Agency of Medicines", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "serious adverse events", 
                "safety_issue": "Yes", 
                "time_frame": "12 months"
            }, 
            {
                "measure": "inflammatory changes", 
                "safety_issue": "Yes", 
                "time_frame": "12 months"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01948934"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "inflammatory condition of the wound,surface,", 
                "measure": "wound evaluation", 
                "safety_issue": "Yes", 
                "time_frame": "12 months"
            }, 
            {
                "description": "anti Human Leukocyte Antigen 1 (HLA1),Short Tandem Repeat (STRS) detection", 
                "measure": "immunological evaluation", 
                "safety_issue": "Yes", 
                "time_frame": "12 months"
            }, 
            {
                "description": "Transforming growth factor beta 1 or Transforming growth factor beta (TGFB),wound biopsy", 
                "measure": "histological evaluation", 
                "safety_issue": "Yes", 
                "time_frame": "12 months"
            }, 
            {
                "description": "microbiological culture", 
                "measure": "microbiological evaluation", 
                "safety_issue": "Yes", 
                "time_frame": "12 months"
            }
        ], 
        "source": "Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2012", 
        "study_design": "Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}